ArticlePloS one2023
Deep learning hybrid model for analyzing and predicting the impact of imported malaria cases from Africa on the rise of Plasmodium falciparum in China before and during the COVID-19 pandemic.
Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Metagenomic profiling of pathogens and antibiotic resistome in influent of six municipal wastewater treatment plants: a descriptive analysis of plant-specific microbial hazards.Frontiers in microbiology · 2026Article
- Epidemiological and clinical characteristics of imported malaria patients admitted to a specialized hospital: a retrospective study (2021- June 2026).Frontiers in cellular and infection microbiology · 2026Observational
- Impact of the COVID-19 pandemic on malaria transmission in the state of Pará, Brazil.Malaria journal · 2025Observational
- Article
- Progress towards malaria elimination in the Greater Mekong Subregion: perspectives from the World Health Organization.Malaria journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPlasmodium falciparum cases are rising in China due to the imported malaria cases from African countries. The main goal of this study is to examine the impact of imported malaria cases in African countries on the rise of P. falciparum cases in China before and during the COVID-19 pandemic.
methodsA generalized regression model was used to investigate the association of time trends between imported malaria cases from 45 African countries and P. falciparum cases in 31 provinces of China from 2012 to 2018 before the COVID-19 pandemic and during the COVID-19 pandemic from October 2020 to May 2021. Based on the analysis, we proposed a statistical and deep learning hybrid approach to model the resurgence of malaria in China using monthly data of P. falciparum from 2004 to 2016. This study builds a hybrid model known as the ARIMA-GRU approach for modeling the P. falciparum cases in all provinces of China and the number of malaria deaths in China before and during the COVID-19 pandemic.
resultsThe analysis showed an emerging link between the rise of imported malaria cases from Africa and P. falciparum cases in many provinces of China. Many imported malaria cases from Africa were P. falciparum cases. The proposed deep learning model achieved a high prediction accuracy score on the testing dataset of 96%.
conclusionThe study provided an analysis of the reduction of P. falciparum cases and deaths caused by imported P. falciparum cases during the COVID-19 pandemic due to the control measures regarding the limitation of international travel in China. The Chinese government has to prepare the imported malaria control measures after the normalization of international travel, to prevent the resurgence of malaria disease in China.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.